Additionally, one-way logistic regression analysis of the significantly different variables showed that HER2 status, tumor size, radiotherapy, chemotherapy, surgical treatment, and TN staging may be risk factors for the development of cancer metastasis in patients with IDC. This evidence concerns the gene ERBB2 and cancer.